These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15231590)

  • 1. Collecting and sharing information about harms.
    Pirmohamed M; Darbyshire J
    BMJ; 2004 Jul; 329(7456):6-7. PubMed ID: 15231590
    [No Abstract]   [Full Text] [Related]  

  • 2. Making the most of spontaneous adverse drug reaction reporting.
    Waller PC
    Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):320-3. PubMed ID: 16611209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case reports of suspected adverse drug reactions: case reports generate signals efficiently.
    Russmann S
    BMJ; 2006 Feb; 332(7539):488. PubMed ID: 16497771
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse drug reactions--no farewell to harms.
    Aronson JK
    Br J Clin Pharmacol; 2007 Feb; 63(2):131-5. PubMed ID: 17274787
    [No Abstract]   [Full Text] [Related]  

  • 5. Balancing benefits and harms in health care: GPs need to be informed about drugs prescribed to their patients elsewhere.
    Randev P
    BMJ; 2004 Aug; 329(7463):457; discussion 458-9. PubMed ID: 15321909
    [No Abstract]   [Full Text] [Related]  

  • 6. Low quality of reporting adverse drug reactions in paediatric randomised controlled trials.
    de Vries TW; van Roon EN
    Arch Dis Child; 2010 Dec; 95(12):1023-6. PubMed ID: 20551194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Underreporting adverse drug reactions--limitations of the Dutch Hospital Data database].
    Dijkers FW
    Ned Tijdschr Geneeskd; 2013; 157(6):A5563. PubMed ID: 23388140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regional Centers of Pharmacovigilance: a complementary source of efficiency].
    Mazé F; Bégaud B
    Therapie; 1998; 53(4):397-400. PubMed ID: 9806011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interpretation of adverse drug reaction reporting and monitoring and significance of traditional Chinese medicine adverse drug reaction monitoring].
    Wang D; Du XX
    Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2686-8. PubMed ID: 23285908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction reporting--2000: Part 1.
    Sutcliffe H
    CMAJ; 2001 Apr; 164(7):1038, 1042. PubMed ID: 11314437
    [No Abstract]   [Full Text] [Related]  

  • 11. [Adverse events and adverse reactions associated with drugs--important actual spontaneous reporting of the drug event].
    Homma M
    Ryumachi; 1992 Oct; 32(5):429-31. PubMed ID: 1440077
    [No Abstract]   [Full Text] [Related]  

  • 12. A quantitative analysis of adverse events and "overwarning" in drug labeling.
    Duke J; Friedlin J; Ryan P
    Arch Intern Med; 2011 May; 171(10):944-6. PubMed ID: 21606101
    [No Abstract]   [Full Text] [Related]  

  • 13. Invited commentary--prescription drug label adverse events: a call for prioritization: comment on "A quantitative analysis of adverse events and 'overwarning' in drug labeling".
    Cheng C; Guglielmo BJ
    Arch Intern Med; 2011 May; 171(10):946-7. PubMed ID: 21606102
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristics and quality of adverse drug reaction reports by pharmacists in Norway.
    Gedde-Dahl A; Harg P; Stenberg-Nilsen H; Buajordet M; Granas AG; Horn AM
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):999-1005. PubMed ID: 17457794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experts call for active surveillance of drug safety.
    Wadman M
    Nature; 2007 Mar; 446(7134):358-9. PubMed ID: 17377551
    [No Abstract]   [Full Text] [Related]  

  • 16. Need for monitoring adverse drug reactions.
    Nerurkar RP; Nadkar MY; Bichile SK
    J Assoc Physicians India; 1998 Aug; 46(8):673-4. PubMed ID: 11229269
    [No Abstract]   [Full Text] [Related]  

  • 17. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
    Wester K; Jönsson A; Spigset O; Hägg S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study finds problems with reporting side effects.
    TreatmentUpdate; 2002 Jul; 14(5):3-4. PubMed ID: 12141280
    [No Abstract]   [Full Text] [Related]  

  • 19. Studying the causes of adverse drug reactions: circumvent the warning-interfered bias using the case-case comparison approach.
    Wang LY; Lee WC
    J Clin Epidemiol; 2008 May; 61(5):516. PubMed ID: 18394547
    [No Abstract]   [Full Text] [Related]  

  • 20. [A regional center for reporting adverse drug reactions in Umeå. Prompt handling results in quick feedback].
    Bäckström M; Dahlqvist R; Mjörndal T; Spigset O; Hedenmalm K; Granberg K; Oqvist U; Wiholm BE
    Lakartidningen; 1995 Jan; 92(3):148-50. PubMed ID: 7837847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.